These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 26756252)

  • 1. Study of a Bifunctional Aβ Aggregation Inhibitor with the Abilities of Antiamyloid-β and Copper Chelation.
    Zhang Q; Hu X; Wang W; Yuan Z
    Biomacromolecules; 2016 Feb; 17(2):661-8. PubMed ID: 26756252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tripeptide GGH as the Inhibitor of Copper-Amyloid-β-Mediated Redox Reaction and Toxicity.
    Hu X; Zhang Q; Wang W; Yuan Z; Zhu X; Chen B; Chen X
    ACS Chem Neurosci; 2016 Sep; 7(9):1255-63. PubMed ID: 27433833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamics in Alzheimer's disease model rats of a bifunctional peptide with the potential to accelerate the degradation and reduce the toxicity of amyloid β-Cu fibrils.
    Wang D; Zhang Q; Hu X; Wang W; Zhu X; Yuan Z
    Acta Biomater; 2018 Jan; 65():327-338. PubMed ID: 29111371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of nonapeptide LVFFARKHH: A bifunctional agent against Cu
    Zhang H; Zhang C; Dong XY; Zheng J; Sun Y
    J Mol Recognit; 2018 Jun; 31(6):e2697. PubMed ID: 29318655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RTHLVFFARK-NH
    Meng J; Zhang H; Dong X; Liu F; Sun Y
    J Inorg Biochem; 2018 Apr; 181():56-64. PubMed ID: 29407908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of Cu-amyloid-β by using bifunctional peptides with β-sheet breaker and chelator moieties.
    Jensen M; Canning A; Chiha S; Bouquerel P; Pedersen JT; Østergaard J; Cuvillier O; Sasaki I; Hureau C; Faller P
    Chemistry; 2012 Apr; 18(16):4836-9. PubMed ID: 22422637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. d-Enantiomeric RTHLVFFARK-NH
    Liu W; Dong X; Sun Y
    ACS Chem Neurosci; 2019 Mar; 10(3):1390-1401. PubMed ID: 30650306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carnosine-LVFFARK-NH
    Zhang H; Dong X; Sun Y
    ACS Chem Neurosci; 2018 Nov; 9(11):2689-2700. PubMed ID: 30036471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metal-Organic Frameworks Harness Cu Chelating and Photooxidation Against Amyloid β Aggregation in Vivo.
    Yu D; Guan Y; Bai F; Du Z; Gao N; Ren J; Qu X
    Chemistry; 2019 Mar; 25(14):3489-3495. PubMed ID: 30601592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zn(II)- and Cu(II)-induced non-fibrillar aggregates of amyloid-beta (1-42) peptide are transformed to amyloid fibrils, both spontaneously and under the influence of metal chelators.
    Tõugu V; Karafin A; Zovo K; Chung RS; Howells C; West AK; Palumaa P
    J Neurochem; 2009 Sep; 110(6):1784-95. PubMed ID: 19619132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conjugation of RTHLVFFARK to human lysozyme creates a potent multifunctional modulator for Cu
    Li X; Wang W; Dong X; Sun Y
    J Mater Chem B; 2020 Mar; 8(11):2256-2268. PubMed ID: 32100783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new water-soluble Cu(II) chelator that retrieves Cu from Cu(amyloid-β) species, stops associated ROS production and prevents Cu(II)-induced Aβ aggregation.
    Noël S; Perez F; Pedersen JT; Alies B; Ladeira S; Sayen S; Guillon E; Gras E; Hureau C
    J Inorg Biochem; 2012 Dec; 117():322-5. PubMed ID: 22819647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effect of human serum albumin on Cu-induced Aβ(40) aggregation and toxicity.
    Lu N; Yang Q; Li J; Tian R; Peng YY
    Eur J Pharmacol; 2015 Nov; 767():160-4. PubMed ID: 26463036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metal ions and intrinsically disordered proteins and peptides: from Cu/Zn amyloid-β to general principles.
    Faller P; Hureau C; La Penna G
    Acc Chem Res; 2014 Aug; 47(8):2252-9. PubMed ID: 24871565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The second Cu(II)-binding site in a proton-rich environment interferes with the aggregation of amyloid-beta(1-40) into amyloid fibrils.
    Jun S; Gillespie JR; Shin BK; Saxena S
    Biochemistry; 2009 Nov; 48(45):10724-32. PubMed ID: 19824649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Aβ peptide aggregation by ruthenium(II) polypyridyl complexes through copper chelation.
    Peng YB; Tao C; Tan CP; Zhao P
    J Inorg Biochem; 2021 Nov; 224():111591. PubMed ID: 34450410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A bifunctional non-natural tetrapeptide modulates amyloid-beta peptide aggregation in the presence of Cu(ii).
    Márquez M; Blancas-Mejía LM; Campos A; Rojas L; Castañeda-Hernández G; Quintanar L
    Metallomics; 2014 Dec; 6(12):2189-92. PubMed ID: 25350343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation effect of acidulated human serum albumin on Cu
    Xie B; Liu F; Dong X; Wang Y; Liu XM; Sun Y
    J Inorg Biochem; 2017 Jun; 171():67-75. PubMed ID: 28371680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Copper(I) Chelators for Alzheimer's Disease.
    Opare SKA; Rauk A
    J Phys Chem B; 2017 Dec; 121(50):11304-11310. PubMed ID: 29172520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bifunctional backbone modified squaramide dipeptides as amyloid beta (Aβ) aggregation inhibitors.
    Dattatray Shinde S; Kumar Behera S; Kulkarni N; Dewangan B; Sahu B
    Bioorg Med Chem; 2024 Jan; 97():117538. PubMed ID: 38056379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.